Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Lexeo Therapeutics Q4 EPS $(0.86) Up From $(8.86) YoY

Author: Happy Mohamed | March 11, 2024 07:55am
Lexeo Therapeutics (NASDAQ:LXEO) reported quarterly losses of $(0.86) per share. This is a 90.29 percent increase over losses of $(8.86) per share from the same period last year.

Posted In: LXEO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist